Prev Close | 372.60 |
Day Low/High | 371.19 / 376.54 |
52 Wk Low/High | 244.10 / 379.13 |
Prev Close | 372.60 |
Day Low/High | 371.19 / 376.54 |
52 Wk Low/High | 244.10 / 379.13 |
Exchange | NYSE |
Shares Outstanding | 244.91B |
Market Cap | 91.25B |
P/E Ratio | 16.20 |
Div & Yield | N.A. (N.A) |
This week on Wall Street, investors will get quarterly results from Apple, a Federal Reserve meeting and the January jobs report.
Futures are indicating a more than 100-point gain for the Dow Jones Industrial Average on the first trading day of 2017.
Let's look at the top five winners and see if they gave us all they could.
January Brent Crude oil is trading at 3 week highs. OPEC appears to be moving closer to reaching an agreement to cut output when it meets next week.
After today's rally, what happens next?
Shares of the benefits manager were climbing on the bank's sunny forecast.
Shares of the insurance giant were slipping on a price-target cut and downgrade to neutral.
Hasbro shares spike on news of a better-than-expected earnings thanks to robust sales growth among girls' toys.
A close below $121 is a sign you have stayed too long.
But even if Dow/DuPont merger fails, Dow is in good stead.
Talk surrounding the much-anticipated $46 billion tie-up between the two health insurers may soon be revived.
Cigna and Anthem shares are climbing on renewed hopes of an insurance tie-up.
Rising costs of benefits affects employees and employers.
A slew of corporate earnings and closely watched Federal Reserve meeting are in focus for the week of July 25.
Quarterly reports continued to come in at breakneck speed with some of the key highlights including American Express, eBay, General Motors, Southwest Airlines, and Biogen.
Reports that two big HMO deals will be blocked, a decline in oil and political fear-mongering aren't dragging this market down.
Even if its deal with Cigna doesn't go through, the insurer still has good opportunities to pursue.
U.S. stocks rallied on Monday as a new poll suggested the UK may remain in the European Union, ahead of the critical referendum on Thursday.
Without it, any rally would just be a short-covering bump.
Bayer has gone public with its offer to by Monsanto and it's a whopper.
Look for ANTM to retest the February lows around $120.
Jim Cramer awaits quarterly results from Halliburton and Express Scripts, due out on Monday.
Candidates have decried rising drug and medical prices, but there are reasons to like these stocks.
Higher oil prices are helping stocks like Freeport-McMoran, according to Jim Cramer, portfolio manager of the Action Alerts PLUS charitable.
Don't be surprised if Anthem's threat to take its business elsewhere results in a compromise.
U.S. futures are down ahead of the final day of the Fed's 2-day policy meeting on Wednesday.